Lucid Diagnostics Inc. (LUCD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts LUCD Hot Sheet
Join SI Premium – FREE
Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $830 thousand versus the consensus estimate of $1.87 million.
For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Boost Run signs lease with 10X Capital for up to 111 MW of GPU capacity
- Tenon Medical (TNON) Misses Q2 EPS by 395c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
